Givaudan | GIVN - Selling And Administration Expenses

Stock Price
2,948.00
Daily Change
-29.00 -0.97%
Monthly
-5.09%
Yearly
-24.64%
Q1 Forecast
2,915.39

Givaudan reported CHF294.5M in Selling and Administration Expenses for its fiscal semester ending in June of 2024.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 783M 43M Sep/2025
Anheuser-Busch USD 4.54B 89M Sep/2025
Arkema EUR 231M 11M Sep/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
British American Tobacco GBP 687.5M 611.5M Jun/2024
Covestro EUR 437M 12M Sep/2025
Danone EUR 4.87B 141M Jun/2025
Diageo GBP 1.9B 1.03B Dec/2024
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Givaudan CHF 294.5M 229.5M Jun/2024
Glanbia EUR 310.1M 68M Jan/2025
Heineken EUR 1.1B 52M Jun/2025
Henkel EUR 3.45B 213M Jun/2025
International Flavors Fragrances USD 421M 62M Sep/2025
Johnson Matthey GBP 170M 87M Dec/2025
L'Oréal EUR 4.19B 6.74B Jun/2025
Merck EUR 1.46B 16M Sep/2025
Nestle CHF 12.73B 181M Jun/2025
Pernod Ricard EUR 955M 833M Jun/2025
SGS CHF 3M 1.7B Dec/2024
Solvay EUR 115M 1000K Sep/2025
Victrex GBP 34.7M 4M Dec/2025